Survival from cancer varies with many factors, including: demographic characteristics, tumour type, stage of the cancer at diagnosis, co-morbidities, other prognostic indicators
Survival from cancer can be influenced by various factors including demographic characteristics, tumour type, stage of the cancer at diagnosis, other prognostic indicators and a
The MIR provides a crude measure of the fatality of a selected cancer type relative to other cancers (higher MIR values indicate poorer survival).1,2 The MIR can hel
The measure "Radiotherapy treatment activity" presents data for radiotherapy services delivered in Australia between 2013 and 2015, as indicated by reimbursement claims under th
Relative survival by stage at diagnosis (lung cancer)
5311
2700
4
This measure presents national survival by stage at diagnosis data for lung cancer in Australia using data sources that are routinely accessible to all cancer registries.
About 90% (Australian men) and 65% (Australian women) of lung cancers are attributable to tobacco smoking.3 It is projected that in Australia in 2019, 7,184 males and
This measure shows the number of people receiving at least one of the cancer-related systemic therapies and a small number of supportive treatments in Australia in any one year
